123-03-5
CAS 123-03-5
123-03-5 (CAS 123-03-5) is a pharmaceutical compound with 7 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 14574.91 nM | 20 | - |
| - | MIC | 26907.69230769231 nM | 13 | - |
| - | MIC | 19.39923076923077 ug.mL-1 | 13 | - |
| - | MIC | 6 p.p.m. | 5 | - |
| - | EC50 | 21000 nM | 1 | - |
| - | Ki | 32062.69 nM | 1 | - |
| - | MIC | 1 (ug of base) ml-1 | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| CETYLPYRIDINIUM CHLORIDE ANHYDROUS | 1311527 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 123-03-5 used for in pharmaceutical contexts?
123-03-5 (CAS 123-03-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 123-03-5?
No adverse-event association or SIDER side-effect rows are rendered for 123-03-5 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 123-03-5 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Cetylpyridinium Chloride with EU status "permitted".
What clinical phase is 123-03-5 in?
No phase 1-4 clinical development badge is rendered for 123-03-5 because the matched compound identifier rows do not contain a max-phase value.